John Oyler, co-founder and CEO of BeiGene, says his company is working on developing a range of new cancer drugs. Photo: Handout

CEO of China oncology start-up BeiGene toils to bring drugs to fruition

John Oyler says the primary goal is to get quick approval for the company’s pipeline of drugs to help patients fight a range of illnesses

Topic |   Medicine

TOP PICKS

John Oyler, co-founder and CEO of BeiGene, says his company is working on developing a range of new cancer drugs. Photo: Handout
READ FULL ARTICLE